Clinical Trial Update: Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating daily doxycycline for prevention of sexually transmitted infections has completed, informing prophylaxis regimens.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sexually Transmitted Infection

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Emory University | Conditions: Sexually Transmitted Infection | Phase 4 | Status: COMPLETED